How to scientifically arrange the taking time of lorlatinib?

Lorlatinib (Lorlatinib), a drug targeting ALK-positive and ROS1-positive advanced non-small cell lung cancer ( The oral third-generation ALK inhibitors for patients with pan>NSCLC have significant efficacy, but the correct way of taking them is also critical to ensuring the therapeutic effect and reducing side effects.

To ensure that lorlatinib maintains a stable blood concentration in the body, it is recommended that patients take it at the same time every day, whether in the morning or evening. The key is to maintain consistency. Such medication habits can maximize the efficacy of the drug while reducing adverse reactions caused by fluctuations in drug concentration.

Although the taking of lorlatinib is not restricted by meals, in order to reduce possible gastrointestinal discomfort, it is recommended that patients take it between half an hour and an hour after a meal, with an appropriate amount of warm water. This approach not only helps reduce the direct irritation of the drug to the stomach, but also helps patients form a regular medication habit and avoid missing doses.

In the face of occasional forgetfulness, the patient should immediately take the next dose. However, if it is less than four hours before the next dose, the patient should give up taking the next dose and directly continue the next dose according to the original plan. It is important not to forget to take a double dose to avoid unnecessary side effects from overdose.

For elderly patients or patients with poor liver and kidney function, the medication time or dosage should be adjusted according to the doctor's personalized recommendations. At the same time, patients should pay close attention to their own reactions during medication. Once significant adverse reactions such as hyperlipidemia and peripheral neuropathy occur, they should communicate with their doctors in a timely manner. The medication time or regimen may need to be adjusted accordingly.

To sum up, the best strategy for taking lorlatinib is to take it at a fixed time every day, after meals, and maintain this regularity. This not only ensures maximum drug efficacy, but also effectively reduces the risk of drug resistance. Patients should maintain close communication with their doctors throughout the entire treatment process and jointly monitor body reactions to ensure the safety and effectiveness of the treatment.

xa0

Reference materials

1.Pfizer official website:

https://www.pfizer.com

2.UpToDate - Lorlatinib overview and dosing:

https://www.uptodate.com/contents/lorlatinib-for-alk-positive-non-small-cell-lung-cancer